You are here

Clinical Trials: Cardiovascular Diseases



Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, November 16, 2016 - 20:00
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: Platelet Lysate;   Biological: Platelet Poor Plasma
Sponsor:   University of Jordan
Not yet recruiting - verified November 2016
Posted: Wednesday, November 9, 2016 - 20:00
Condition:   Wound, Nonpenetrating
Interventions:   Device: Transpose ® RT System;   Other: debridement/dressing of wound
Sponsor:   InGeneron, Inc.
Not yet recruiting - verified March 2017
Posted: Thursday, October 20, 2016 - 19:00
Conditions:   Foramen Ovale, Patent;   Heart Septal Defects, Atrial;   Atrial Septal Defect
Intervention:   Other: Blood samples
Sponsor:   University Hospitals of North Midlands NHS Trust
Recruiting - verified November 2016
Posted: Wednesday, October 19, 2016 - 19:00
Condition:   Acute Coronary Syndrome
Interventions:   Drug: Atorvastatin;   Other: Blood samples
Sponsor:   University Hospitals of North Midlands NHS Trust
Recruiting - verified November 2016
Posted: Monday, October 3, 2016 - 19:00
Condition:   Heart Failure With Normal Ejection Fraction
Interventions:   Biological: Cell Therapy;   Biological: Control Procedure
Sponsor:   University Medical Centre Ljubljana
Recruiting - verified October 2016
Posted: Tuesday, September 27, 2016 - 19:00
Condition:   Thoracic or Abdominal Aortic Aneurysm With no Indication for Surgical Treatment
Intervention:   Biological: blood taking
Sponsor:   Centre Hospitalier Universitaire de Besancon
Recruiting - verified September 2016
Posted: Thursday, September 22, 2016 - 19:00
Condition:   Peripheral Arterial Disease
Interventions:   Biological: G-CSF + CD133(+) cells;   Biological: G-CSF;   Procedure: percutaneous transluminal angioplasty (PTA);   Biological: Placebo infusion
Sponsor:   Shanghai 10th People's Hospital
Recruiting - verified September 2016
Posted: Monday, September 19, 2016 - 19:00
Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: Fulvestrant
Sponsor:   University of Pennsylvania
Not yet recruiting - verified September 2016
Posted: Wednesday, August 31, 2016 - 19:00
Condition:   Coronary Artery Disease
Interventions:   Drug: ticagrelor;   Drug: clopidogrel
Sponsor:   First Affiliated Hospital of Harbin Medical University
Recruiting - verified August 2016
Posted: Wednesday, August 24, 2016 - 19:00
Condition:   Neonatal Hypoxic-ischaemic Encephalopathy
Intervention:   Drug: autologous cord blood stem cell
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016